Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 9.28
+0.04 (0.43%)
Feb 23, 2026, 3:58 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 693.81 million as of February 23, 2026. Its market cap has increased by 80.21% in one year.
Market Cap
693.81M
Enterprise Value
623.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.28
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 693.81M, a decrease of -3.71%. That is a compound annual growth rate of -0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 693.81M | 2.87% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.55B |
| Nykode Therapeutics AS | 1.17B |
| ArcticZymes Technologies ASA | 1.16B |
| Zelluna ASA | 472.86M |
| Circio Holding ASA | 369.64M |
| SoftOx Solutions AS | 133.46M |
| EXACT Therapeutics AS | 107.55M |
| Arctic Bioscience AS | 86.26M |